Abstract: A water filtration system is provided comprising first and second banks of water filter assemblies, wherein the system is arranged to provide filtered water from one bank of water filter assemblies while using some of the filtered water to reverse flush the other bank of water filtration assemblies. A method of filtering water by passing it through the system is also provided.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be metabolized in vivo to HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: The compounds encompassed by Formula I include compounds which are HIV protease inhibitors and other compounds which can be metabolized in vivo to HIV protease inhibitors. The compounds and their pharmaceutically acceptable salts are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.

Abstract: A colored glass curtain wall for a building and a method for constructing the glass curtain wall are disclosed. The colored glass curtain wall comprises a plurality of individual panels interconnected by a support frame. Each individual panel has an inboard sheet and an outboard sheet, both of which are preferably made of glass. At least part of the interior surface of the outboard glass sheet is preferably roughened by either a sandblasting or etching process. The exterior surface of the inboard sheet has a coating of opaque paint corresponding to the roughened portion. A reflective coating may also be applied to either the inboard or outboard sheet.

Abstract: A method for reconditioning a length of air core cable and for discharging moisture from the cable. Gas under pressure is forced into one end of the cable to cause discharge of moisture from an opposite end of the cable. A quantity of fluid solvent and lubricant is injected into the end of the cable and forced by gas under pressure as a unitary charge along the length of the cable.

Abstract: An anchoring system and method for fastening a plurality of veneer units (12) to a substrate wall (11) with a waterproof membrane (13) therebetween. The anchoring system (10) comprises a membrane-holding means (14) which is attached to the substrate wall (11) and holds the membrane proximate the wall (11) without puncturing the membrane (13). The anchoring system (10) also includes a support and tie structure (20) including a stationary anchor (19) and a vertically slidable, horizontal tie (24) which is positioned between adjacent units of veneer (12) for stabilization of the veneer wall. The invention further includes means for interconnecting the support and tie structure to the membrane-holding means. In one embodiment of the invention, this interconnecting means comprises a base channel (33) having upper and lower, outwardly extending horizontal legs. The base channel (33) has a central aperture (36) which accommodates the membrane-holding means (14).

Abstract: A solar concentrator having a stationary reflective collector (20) located to view the sky and reflect solar energy to a stationary reflective reflector (30) positioned to receive such reflected energy and reflect the energy toward a target within a structure through a side wall (19). A low angle shield (32) prevents most direct rays from entering, unreflected, into a work space inside the structure and a shield (36) prevents solar energy, reflected by the collector (20) and the reflector (30) from penetrating a plane (38) space above the floor a distance generally equal to the height of the eye of an occupant standing on the floor of the structure.

Abstract: A passive solar lighting system is disclosed. A multiplyer lens (20) located within an aperture (12) in a building (10) increases the cone of light acceptance which would result in the absence of lens (20). Light passing through lens (20) is further refracted by lenses (22, 24) and the resultant light is thereby directed to a target area (14) for interior lighting.

Abstract: Anaerobic curing compositions are disclosed containing from 1-50% by weight of a low molecular weight, reactive, elastomer forming polymer containing a reactive CH.sub.2 .dbd.C(R)C(O)O--, COOH, SH, SO.sub.2 Cl or NH.sub.2 group.

Abstract: A treatment for trees infected with fungus diseases producing characteristic wilt which comprises injecting a solution including as the active ingredient thereof a halogenated compound structurally similar to the lignin. Typical examples include halogenated compounds of the creosols, catechol and dimethoxy toluene.

Abstract: In one aspect, the invention is related to a method of treating a patient with Parkinson's disease, the method including administering to the respiratory tract of the patient particles that include more than about 90 weight percent (wt %) of levodopa. The particles are delivered to the patient's pulmonary system, preferably to the alveoli or the deep lung.